Literature DB >> 1993762

Molecular analysis of variant plasmid forms of a bivalent Salmonella typhi-Shigella sonnei vaccine strain.

A B Hartman1, M M Ruiz, C L Schultz.   

Abstract

The Salmonella typhi-Shigella sonnei hybrid vaccine strain 5076-IC was constructed to express the S. sonnei form I antigen, which may play an important role in producing protective immunity. Three clonal variants which existed in preparations of the vaccine could be distinguished phenotypically by lactose utilization, S. sonnei form I antigen expression, and restriction enzyme analysis of large plasmid DNA. Since expression of the form I antigen was lost in two of the clonal variants, genetic instability of the 120-MDa vaccine plasmid appeared to be a potential problem. To examine the molecular basis of this genetic instability, we hybridized large plasmid DNA isolated from the clonal variants to a variety of DNA probes encoding virulence-associated antigens and to Escherichia coli lacZ DNA. Results indicated that DNA rearrangement accompanied by deletions of plasmid material occurred in the vaccine plasmid. In addition, the vaccine plasmid did not contain some S. sonnei genetic material encoding antigenic polypeptides necessary for virulence.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993762      PMCID: PMC269696          DOI: 10.1128/jcm.29.1.27-32.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Studies in shigellosis. III. A controlled evaluation of a monovalent Shigella vaccine in a highly endemic environment.

Authors:  A R HIGGINS; T M FLOYD; M A KADER
Journal:  Am J Trop Med Hyg       Date:  1955-03       Impact factor: 2.345

2.  Characterization of invasion plasmid antigen genes (ipaBCD) from Shigella flexneri.

Authors:  M M Venkatesan; J M Buysse; D J Kopecko
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Shigellosis in custodial institutions. 3. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated shigella vaccines.

Authors:  M M Levine; E J Gangarosa; M Werner; G K Morris
Journal:  J Pediatr       Date:  1974-06       Impact factor: 4.406

4.  Comparison of DNA probes and the Sereny test for identification of invasive Shigella and Escherichia coli strains.

Authors:  P K Wood; J G Morris; P L Small; O Sethabutr; M R Toledo; L Trabulsi; J B Kaper
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

Review 5.  Transposable elements in prokaryotes.

Authors:  N Kleckner
Journal:  Annu Rev Genet       Date:  1981       Impact factor: 16.830

6.  Study on the effect of oral immunization of T32-Istrati strain against bacillary dysentery in field trials.

Authors:  W Bingrui
Journal:  Arch Roum Pathol Exp Microbiol       Date:  1984 Jul-Dec

7.  Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati).

Authors:  T Meitert; E Pencu; L Ciudin; M Tonciu
Journal:  Arch Roum Pathol Exp Microbiol       Date:  1984 Jul-Dec

8.  Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin.

Authors:  M L Bernardini; J Mounier; H d'Hauteville; M Coquis-Rondon; P J Sansonetti
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

9.  Genetic and physical evidence for plasmid control of Shigella sonnei form I cell surface antigen.

Authors:  D J Kopecko; O Washington; S B Formal
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

10.  Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial.

Authors:  D M Mel; A L Terzin; L Vuksić
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

View more
  5 in total

Review 1.  Recombinant avirulent salmonellae as oral vaccine carriers.

Authors:  F Schödel
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

Review 2.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

3.  Virulence plasmid instability in Shigella flexneri 2a is induced by virulence gene expression.

Authors:  R Schuch; A T Maurelli
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

4.  Development of Shigella sonnei live oral vaccines based on defined rfbInaba deletion mutants of Vibrio cholerae expressing the Shigella serotype D O polysaccharide.

Authors:  D Favre; S J Cryz; J F Viret
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

5.  Molecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live salmonella vaccine vector.

Authors:  De-Qi Xu; John O Cisar; Nicholas Ambulos; Donald H Burr; Dennis J Kopecko
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.